Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$21.99 USD
+0.52 (2.42%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $21.96 -0.03 (-0.14%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (81 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.36 | 9.99 |
Current Quarter Estimate | -0.70 | 2.97 | 61.00 |
Year Ago Quarter Estimate | -0.61 | -4.89 | 54.84 |
Next Quarter Estimate | 0.28 | 4.11 | 63.00 |
Next Year Estimate | 0.21 | 25.30 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -30.65 | 18.30 | 15.67 |
Next Year | 108.08 | 9.20 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.33 |
Price/Book (MRQ) | 2.29 | 2.01 |
Price/Cash Flow (MRFY) | NA | 14.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -41.21% | -140.17% |
Return on Equity (TTM) | -25.47% | -58.18% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.